Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 21
2008 43
2009 60
2010 66
2011 74
2012 89
2013 72
2014 68
2015 71
2016 62
2017 53
2018 81
2019 71
2020 12
Text availability
Article attribute
Article type
Publication date

Search Results

735 results
Results by year
Filters applied: . Clear all
Page 1
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, Brenner B, Kakkar A, Rafii H, Solymoss S, Brilhante D, Monreal M, Bounameaux H, Pabinger I, Douketis J; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. Farge D, et al. Lancet Oncol. 2019 Oct;20(10):e566-e581. doi: 10.1016/S1470-2045(19)30336-5. Epub 2019 Sep 3. Lancet Oncol. 2019. PMID: 31492632
Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
Sterne JA, Bodalia PN, Bryden PA, Davies PA, López-López JA, Okoli GN, Thom HH, Caldwell DM, Dias S, Eaton D, Higgins JP, Hollingworth W, Salisbury C, Savović J, Sofat R, Stephens-Boal A, Welton NJ, Hingorani AD. Sterne JA, et al. Health Technol Assess. 2017 Mar;21(9):1-386. doi: 10.3310/hta21090. Health Technol Assess. 2017. PMID: 28279251 Free PMC article. Review.
SETTING: Hospital (VTE primary prevention and acute treatment) and primary care/anticoagulation clinics (AF and VTE secondary prevention). ...RESULTS: Apixaban (Eliquis(®), Bristol-Myers Squibb, USA; Pfizer, USA) [5 mg bd (twice daily)] was ranked as among th …
SETTING: Hospital (VTE primary prevention and acute treatment) and primary care/anticoagulation clinics (AF and VTE secondary prevent …
Prevention of venous thromboembolism in gynecologic oncology surgery.
Barber EL, Clarke-Pearson DL. Barber EL, et al. Gynecol Oncol. 2017 Feb;144(2):420-427. doi: 10.1016/j.ygyno.2016.11.036. Epub 2016 Nov 25. Gynecol Oncol. 2017. PMID: 27890280 Free PMC article. Review.
Current venous thromboembolism prophylaxis strategies include mechanical prophylaxis, preoperative pharmacologic prophylaxis, postoperative pharmacologic prophylaxis and extended duration pharmacologic prophylaxis that the patient continues at home after hospital discharge …
Current venous thromboembolism prophylaxis strategies include mechanical prophylaxis, preoperative pharmacologic prophylaxis, postoperative …
Cancer and Venous Thromboembolic Disease: A Review.
Donnellan E, Khorana AA. Donnellan E, et al. Oncologist. 2017 Feb;22(2):199-207. doi: 10.1634/theoncologist.2016-0214. Epub 2017 Feb 7. Oncologist. 2017. PMID: 28174293 Free PMC article. Review.
In general, thromboprophylaxis is recommended for most patients hospitalized with active cancer. Furthermore, outpatient thromboprophylaxis may be used in carefully selected high-risk ambulatory patients. ...
In general, thromboprophylaxis is recommended for most patients hospitalized with active cancer. Furthermore, outpatient thromboproph …
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.
Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Prestrud AA, Falanga A; American Society of Clinical Oncology Clinical Practice. Lyman GH, et al. J Clin Oncol. 2013 Jun 10;31(17):2189-204. doi: 10.1200/JCO.2013.49.1118. Epub 2013 May 13. J Clin Oncol. 2013. PMID: 23669224 Review.
Prophylaxis in the outpatient, inpatient, and perioperative settings was considered, as were treatment and use of anticoagulation as a cancer-directed therapy. ...RECOMMENDATIONS: Most hospitalized patients with cancer require thromboprophylaxis throughout hospit
Prophylaxis in the outpatient, inpatient, and perioperative settings was considered, as were treatment and use of anticoagulation as …
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D, Bounameaux H, Brenner B, Cajfinger F, Debourdeau P, Khorana AA, Pabinger I, Solymoss S, Douketis J, Kakkar A. Farge D, et al. Lancet Oncol. 2016 Oct;17(10):e452-e466. doi: 10.1016/S1470-2045(16)30369-2. Lancet Oncol. 2016. PMID: 27733271 Review.
These guidelines aim to address in-hospital and outpatient cancer-associated VTE in specific subgroups of patients with cancer....
These guidelines aim to address in-hospital and outpatient cancer-associated VTE in specific subgroups of patients with cancer....
Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.
Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Somerfield MR, Falanga A; American Society of Clinical Oncology. Lyman GH, et al. J Clin Oncol. 2015 Feb 20;33(6):654-6. doi: 10.1200/JCO.2014.59.7351. Epub 2015 Jan 20. J Clin Oncol. 2015. PMID: 25605844 Free PMC article.
RECOMMENDATIONS: Most hospitalized patients with active cancer require thromboprophylaxis throughout hospitalization. Routine thromboprophylaxis is not recommended for patients with cancer in the outpatient setting. ...
RECOMMENDATIONS: Most hospitalized patients with active cancer require thromboprophylaxis throughout hospitalization. Routine …
Safety and Efficacy of New Anticoagulants for the Prevention of Venous Thromboembolism After Hip and Knee Arthroplasty: A Meta-Analysis.
Venker BT, Ganti BR, Lin H, Lee ED, Nunley RM, Gage BF. Venker BT, et al. J Arthroplasty. 2017 Feb;32(2):645-652. doi: 10.1016/j.arth.2016.09.033. Epub 2016 Oct 5. J Arthroplasty. 2017. PMID: 27823844 Free PMC article. Review.
Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients.
Wang TF, Milligan PE, Wong CA, Deal EN, Thoelke MS, Gage BF. Wang TF, et al. Thromb Haemost. 2014 Jan;111(1):88-93. doi: 10.1160/TH13-01-0042. Epub 2013 Oct 17. Thromb Haemost. 2014. PMID: 24136071 Free PMC article.
Ina retrospective cohort study, we analysed 9,241 inpatients with weight > 100 kg discharged from three hospitals in the BJC HealthCare system from 2010 through 2012. ...The primary efficacy outcome was hospital-acquired VTE identified by International Cla …
Ina retrospective cohort study, we analysed 9,241 inpatients with weight > 100 kg discharged from three hospitals in the BJ …
Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions.
Azboy I, Barrack R, Thomas AM, Haddad FS, Parvizi J. Azboy I, et al. Bone Joint J. 2017 Nov;99-B(11):1420-1430. doi: 10.1302/0301-620X.99B11.BJJ-2017-0337.R2. Bone Joint J. 2017. PMID: 29092979 Free PMC article. Review.
735 results
Jump to page
Feedback